VIKING GLOBAL INVESTORS LP 13D and 13G filings for Zentalis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 5:01 pm Sale |
2021-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
VIKING GLOBAL INVESTORS LP | 2,118,284 4.700% |
-893,000 (-29.66%) |
Filing |
| 2021-02-12 7:52 pm Sale |
2020-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
VIKING GLOBAL INVESTORS LP | 3,011,284 7.400% |
-1,432,000 (-32.23%) |
Filing |